Search research articles
Contact Us
Filters
Showing results (411-420 of 433) with videos related to
Page
of 44
Sort By:
Journal of the American Heart Association
|
December 27, 2024
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
Lynn Ang, Sejal Gunaratnam, Yiyuan Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2006
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders
Anne J Novak, Deanna M Grote, Steven C Ziesmer, et al.
ESMO Open
|
October 24, 2025
Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers
K Muro, K Chin, S B Maron, et al.
F1000Research
|
January 28, 2021
Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity
Evan Bolyen, Matthew R Dillon, Nicholas A Bokulich, et al.
Plos Medicine
|
July 27, 2017
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines
Emilie Alirol, Teodora E Wi, Manju Bala, et al.
Journal of Clinical Microbiology
|
February 24, 2017
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains
W Demczuk, S Sidhu, M Unemo, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 6, 2017
ASHP Guidelines on Preventing Diversion of Controlled Substances
Philip W Brummond, David F Chen, William W Churchill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2001
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist
W Xu, S R Presnell, J Parrish-Novak, et al.
Nature Communications
|
April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
Mark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Insect Molecular Biology
|
February 13, 2013
The characterization of the Phlebotomus papatasi transcriptome
J Abrudan, M Ramalho-Ortigão, S O'Neil, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 433) with videos related to
Sort By:
Page
of 44
Journal of the American Heart Association
|
December 27, 2024
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
Lynn Ang, Sejal Gunaratnam, Yiyuan Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2006
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders
Anne J Novak, Deanna M Grote, Steven C Ziesmer, et al.
ESMO Open
|
October 24, 2025
Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers
K Muro, K Chin, S B Maron, et al.
F1000Research
|
January 28, 2021
Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity
Evan Bolyen, Matthew R Dillon, Nicholas A Bokulich, et al.
Plos Medicine
|
July 27, 2017
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines
Emilie Alirol, Teodora E Wi, Manju Bala, et al.
Journal of Clinical Microbiology
|
February 24, 2017
Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains
W Demczuk, S Sidhu, M Unemo, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 6, 2017
ASHP Guidelines on Preventing Diversion of Controlled Substances
Philip W Brummond, David F Chen, William W Churchill, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2001
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist
W Xu, S R Presnell, J Parrish-Novak, et al.
Nature Communications
|
April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
Mark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Insect Molecular Biology
|
February 13, 2013
The characterization of the Phlebotomus papatasi transcriptome
J Abrudan, M Ramalho-Ortigão, S O'Neil, et al.
Page
of 44